Aridis Pharmaceuticals Inc (ARDS)
0.0615
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Aridis Pharmaceuticals Max Drawdown (5Y): 99.54% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 99.54% |
| March 31, 2024 | 99.53% |
| February 29, 2024 | 99.53% |
| January 31, 2024 | 99.53% |
| December 31, 2023 | 99.53% |
| November 30, 2023 | 99.53% |
| October 31, 2023 | 99.53% |
| September 30, 2023 | 99.48% |
| August 31, 2023 | 99.38% |
| July 31, 2023 | 98.81% |
| June 30, 2023 | 98.81% |
| May 31, 2023 | 98.81% |
| April 30, 2023 | 98.69% |
| March 31, 2023 | 97.71% |
| February 28, 2023 | 95.88% |
| January 31, 2023 | 95.11% |
| December 31, 2022 | 94.68% |
| November 30, 2022 | 94.68% |
| October 31, 2022 | 94.68% |
| September 30, 2022 | 94.68% |
| August 31, 2022 | 93.35% |
| July 31, 2022 | 93.35% |
| June 30, 2022 | 93.35% |
| May 31, 2022 | 93.35% |
| April 30, 2022 | 91.09% |
| Date | Value |
|---|---|
| March 31, 2022 | 90.28% |
| February 28, 2022 | 90.28% |
| January 31, 2022 | 90.28% |
| December 31, 2021 | 85.39% |
| November 30, 2021 | 84.08% |
| October 31, 2021 | 75.97% |
| September 30, 2021 | 74.07% |
| August 31, 2021 | 73.78% |
| July 31, 2021 | 69.61% |
| June 30, 2021 | 69.61% |
| May 31, 2021 | 69.61% |
| April 30, 2021 | 69.61% |
| March 31, 2021 | 69.61% |
| February 28, 2021 | 69.61% |
| January 31, 2021 | 69.61% |
| December 31, 2020 | 69.61% |
| November 30, 2020 | 69.61% |
| October 31, 2020 | 69.61% |
| September 30, 2020 | 69.61% |
| August 31, 2020 | 69.61% |
| July 31, 2020 | 69.61% |
| June 30, 2020 | 69.61% |
| May 31, 2020 | 69.61% |
| April 30, 2020 | 69.61% |
| March 31, 2020 | 69.61% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
42.89%
Minimum
May 2019
99.54%
Maximum
Apr 2024
80.80%
Average
80.02%
Median
Max Drawdown (5Y) Benchmarks
| NovaBay Pharmaceuticals Inc | 99.91% |
| Palatin Technologies Inc | 96.46% |
| iBio Inc | 99.97% |
| Theriva Biologics Inc | 99.81% |
| Oragenics Inc | 98.92% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -77.24 |
| Beta (5Y) | 1.082 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 92.04% |
| Historical Sharpe Ratio (5Y) | -0.7082 |
| Historical Sortino (5Y) | -1.318 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 44.44% |